Virbac: Double-Digit Growth Rates in the Pet Segment - Breakout at a 52-Week High in Sight

Virbac distinguishes itself in the pharmaceutical sector by focusing exclusively on animal health, thus representing a pure "Pure-Play" investment in this niche market. The core business of the French company concentrates on two main pillars: the medical care of pets (small animals like dogs and cats) and livestock. The corporation offers integrated health solutions that range from prevention through vaccines to the treatment of complex pathologies. A special emphasis is placed on innovative niches, such as the dermatological care of animals,...